CMTDIB
MCID: CHR422
MIFTS: 47

Charcot-Marie-Tooth Disease, Dominant Intermediate B (CMTDIB)

Categories: Eye diseases, Genetic diseases, Metabolic diseases, Muscle diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Charcot-Marie-Tooth Disease, Dominant Intermediate B

MalaCards integrated aliases for Charcot-Marie-Tooth Disease, Dominant Intermediate B:

Name: Charcot-Marie-Tooth Disease, Dominant Intermediate B 56 29 6 71
Cmtdib 56 12 58 73
Di-Cmtb 56 12 73
Cmtdi1 56 12 73
Charcot-Marie-Tooth Neuropathy Dominant Intermediate B 12 73
Charcot-Marie-Tooth Disease Dominant Intermediate B 12 15
Charcot-Marie-Tooth Disease, Type 2m 29 6
Cmt2m 58 73
Autosomal Dominant Intermediate Charcot-Marie-Tooth Disease Type B 58
Charcot-Marie-Tooth Disease Axonal Autosomal Dominant Type 2m 73
Charcot-Marie-Tooth Disease, Dominant, Intermediate Type, B 73
Charcot-Marie-Tooth Disease, Dominant Intermediate, Type B 39
Charcot-Marie-Tooth Neuropathy, Dominant Intermediate B 56
Autosomal Dominant Charcot-Marie-Tooth Disease Type 2m 58
Charcot-Marie-Tooth Neuropathy Axonal Type 2m 73
Charcot-Marie-Tooth Disease, Axonal, Type 2m 13
Charcot-Marie-Tooth Disease, Axonal Type 2m 56
Charcot-Marie-Tooth Disease Axonal Type 2m 73
Charcot-Marie-Tooth Disease 2m 73

Characteristics:

Orphanet epidemiological data:

58
autosomal dominant charcot-marie-tooth disease type 2m
Inheritance: Autosomal dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: All ages;

OMIM:

56
Inheritance:
autosomal dominant

Miscellaneous:
onset in first or second decade
begins in feet and legs (peroneal distribution)
features intermediate between demyelinating cmt and axonal cmt
some families have axonal cmt (cmt2m)
genetic heterogeneity (see cmtdia, )


HPO:

31
charcot-marie-tooth disease, dominant intermediate b:
Inheritance autosomal dominant inheritance heterogeneous
Onset and clinical course juvenile onset


Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Disease Ontology 12 DOID:0110197
OMIM 56 606482
OMIM Phenotypic Series 56 PS118220
MeSH 43 D002607
ICD10 32 G60.0
ICD10 via Orphanet 33 G60.0
UMLS via Orphanet 72 C1847902
UMLS 71 C1847902

Summaries for Charcot-Marie-Tooth Disease, Dominant Intermediate B

UniProtKB/Swiss-Prot : 73 Charcot-Marie-Tooth disease 2M: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.
Charcot-Marie-Tooth disease, dominant, intermediate type, B: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The dominant intermediate type B is characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec.

MalaCards based summary : Charcot-Marie-Tooth Disease, Dominant Intermediate B, also known as cmtdib, is related to charcot-marie-tooth disease, axonal, type 2p and charcot-marie-tooth disease, dominant intermediate a. An important gene associated with Charcot-Marie-Tooth Disease, Dominant Intermediate B is DNM2 (Dynamin 2), and among its related pathways/superpathways are Vesicle-mediated transport and Remodeling of Adherens Junctions. Affiliated tissues include eye, and related phenotypes are segmental peripheral demyelination and areflexia

Disease Ontology : 12 A Charcot-Marie-Tooth disease intermediate type that has material basis in mutation in the gene encoding dynamin-2 (DNM2).

OMIM : 56 Charcot-Marie-Tooth disease is a clinically and genetically heterogeneous disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. (606482)

Related Diseases for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Diseases in the Charcot-Marie-Tooth Disease family:

Charcot-Marie-Tooth Disease, Type 4a Charcot-Marie-Tooth Disease, Type 4b1
Charcot-Marie-Tooth Disease, Type 4d Charcot-Marie-Tooth Disease, Type 4c
Charcot-Marie-Tooth Disease, Type 4b2 Charcot-Marie-Tooth Disease, Dominant Intermediate B
Charcot-Marie-Tooth Disease, Dominant Intermediate a Charcot-Marie-Tooth Disease, Dominant Intermediate D
Charcot-Marie-Tooth Disease, Dominant Intermediate C Charcot-Marie-Tooth Disease, Recessive Intermediate a
Charcot-Marie-Tooth Disease, Type 4h Charcot-Marie-Tooth Disease, Type 4j
Charcot-Marie-Tooth Disease, Recessive Intermediate B Charcot-Marie-Tooth Disease, Dominant Intermediate E
Charcot-Marie-Tooth Disease, Dominant Intermediate F Charcot-Marie-Tooth Disease, Type 4b3
Charcot-Marie-Tooth Disease, Recessive Intermediate C Charcot-Marie-Tooth Disease, Recessive Intermediate D
Charcot-Marie-Tooth Disease, Type 4k Charcot-Marie-Tooth Disease, Dominant Intermediate G
Charcot-Marie-Tooth Disease Type X Charcot-Marie-Tooth Disease Intermediate Type
Charcot-Marie-Tooth Disease Type 5 Charcot-Marie-Tooth Disease Type 7
Charcot-Marie-Tooth Disease Type 2a2a Charcot-Marie-Tooth Disease Type 2a2b
Charcot-Marie-Tooth Disease Type 1g Autosomal Dominant Intermediate Charcot-Marie-Tooth
Autosomal Recessive Intermediate Charcot-Marie-Tooth Disease Charcot-Marie-Tooth Disease Type 2a
Charcot-Marie-Tooth Disease Type 2l Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 Due to Kif5a Mutation
Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 Due to Tfg Mutation Dnajb2-Related Charcot-Marie-Tooth Disease Type 2
Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 Due to Dgat2 Mutation Autosomal Dominant Charcot-Marie-Tooth Disease Type 2g

Diseases related to Charcot-Marie-Tooth Disease, Dominant Intermediate B via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 77)
# Related Disease Score Top Affiliating Genes
1 charcot-marie-tooth disease, axonal, type 2p 32.0 LITAF GDAP1
2 charcot-marie-tooth disease, dominant intermediate a 30.9 YARS1 MPZ GJB1 GDAP1 DNM2
3 myopathy, centronuclear, x-linked 10.4 MTM1 DNM2
4 central core myopathy 10.3 MTM1 DNM2
5 argyll robertson pupil 10.3 MPZ GDAP1
6 abnormal pupillary function 10.3 MPZ GDAP1
7 pupil disease 10.3 MPZ GDAP1
8 neuropathy, hereditary motor and sensory, russe type 10.2 SH3TC2 GDAP1
9 early-onset glaucoma 10.2 SBF2 MTMR2 MTM1
10 charcot-marie-tooth disease, axonal, type 2a1 10.2 MPZ GDAP1
11 charcot-marie-tooth disease, axonal, type 2n 10.2 YARS1 GDAP1
12 neuropathy, hereditary sensory and autonomic, type ic 10.2 SH3TC2 LITAF
13 charcot-marie-tooth disease, axonal, type 2b2 10.2 MPZ GDAP1
14 charcot-marie-tooth disease, type 4k 10.2 SH3TC2 LITAF
15 charcot-marie-tooth disease, dominant intermediate d 10.2 YARS1 MPZ DNM2
16 mononeuropathy 10.1 SH3TC2 MPZ
17 nerve compression syndrome 10.1 SH3TC2 MPZ
18 myopathy, centronuclear, 1 10.0 MTMR14 MTM1 DNM2
19 yunis-varon syndrome 10.0 SBF2 MTMR2
20 congenital fiber-type disproportion 10.0 MTMR14 MTM1 DNM2
21 charcot-marie-tooth disease, type 4b3 9.9 SH3TC2 SBF2 MTMR2 GDAP1
22 charcot-marie-tooth disease, dominant intermediate c 9.9 YARS1 MPZ GDAP1 DNM2
23 muscular disease 9.9 MTMR2 MTMR14 MTM1 DNM2
24 charcot-marie-tooth disease, axonal, type 2l 9.9 RAB7A MPZ GDAP1
25 neuropathy, hereditary sensory and autonomic, type i, with cough and gastroesophageal reflux 9.9 RAB7B RAB7A
26 charcot-marie-tooth disease x-linked recessive 4 9.9 MPZ GJB1
27 corneal dystrophy, fleck 9.9 SBF2 MTMR2
28 autoimmune peripheral neuropathy 9.9 MPZ GJB1
29 peripheral demyelinating neuropathy, central dysmyelination, waardenburg syndrome, and hirschsprung disease 9.8 MPZ GJB1
30 charcot-marie-tooth disease, axonal, type 2cc 9.8 MPZ GJB1
31 cataract 8, multiple types 9.7 RAB7B RAB7A DNM2
32 hereditary neuropathies 9.7 MTMR2 MPZ GJB1
33 charcot-marie-tooth disease, axonal, type 2j 9.7 SH3TC2 SBF2 MTMR2 MPZ GDAP1
34 charcot-marie-tooth disease, type 4h 9.7 SH3TC2 SBF2 MTMR2 MPZ GDAP1
35 charcot-marie-tooth disease, axonal, type 2q 9.7 MPZ GJB1
36 pontocerebellar hypoplasia, type 2e 9.6 RAB7B RAB7A
37 hereditary sensory and autonomic neuropathy type 1 9.6 SH3TC2 RAB7A LITAF GDAP1
38 charcot-marie-tooth disease, x-linked recessive, 2 9.6 MPZ LITAF GJB1
39 charcot-marie-tooth disease, dominant intermediate e 9.6 SH3TC2 SBF2 MTMR2 MPZ GDAP1 DNM2
40 charcot-marie-tooth disease, axonal, type 2f 9.5 MTMR2 MPZ GJB1 GDAP1
41 neuropathy, hereditary sensory and autonomic, type iia 9.5 SH3TC2 RAB7B LITAF GDAP1
42 charcot-marie-tooth disease, axonal, type 2d 9.4 YARS1 MPZ GJB1 GDAP1
43 ptosis 9.4 MTMR14 MTM1 GJB1 DNM2
44 motor peripheral neuropathy 9.4 SH3TC2 LITAF GJB1 GDAP1
45 charcot-marie-tooth disease type x 9.3 SH3TC2 MTMR2 MPZ GJB1 GDAP1
46 charcot-marie-tooth disease, demyelinating, type 1d 9.2 MTMR2 MPZ LITAF GJB1 GDAP1
47 charcot-marie-tooth disease type 2a2a 9.1 SH3TC2 MPZ LITAF GJB1 GDAP1
48 charcot-marie-tooth disease, axonal, type 2i 9.1 SH3TC2 MPZ LITAF GJB1 GDAP1
49 polyneuropathy 9.1 SH3TC2 MPZ LITAF GJB1 GDAP1
50 charcot-marie-tooth disease, type 4a 9.1 SH3TC2 SBF2 MTMR2 MPZ GJB1 GDAP1

Graphical network of the top 20 diseases related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:



Diseases related to Charcot-Marie-Tooth Disease, Dominant Intermediate B

Symptoms & Phenotypes for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Human phenotypes related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:

31 (show all 12)
# Description HPO Frequency HPO Source Accession
1 segmental peripheral demyelination 31 occasional (7.5%) HP:0007107
2 areflexia 31 HP:0001284
3 pes cavus 31 HP:0001761
4 hyporeflexia 31 HP:0001265
5 distal amyotrophy 31 HP:0003693
6 distal muscle weakness 31 HP:0002460
7 segmental peripheral demyelination/remyelination 31 HP:0003481
8 distal sensory impairment 31 HP:0002936
9 decreased number of peripheral myelinated nerve fibers 31 HP:0003380
10 onion bulb formation 31 HP:0003383
11 axonal degeneration 31 HP:0040078
12 peripheral axonal degeneration 31 HP:0000764

Symptoms via clinical synopsis from OMIM:

56
Neurologic Peripheral Nervous System:
areflexia
hyporeflexia
distal sensory impairment
axonal degeneration
distal limb muscle weakness due to peripheral neuropathy
more
Skeletal Feet:
pes cavus

Clinical features from OMIM:

606482

MGI Mouse Phenotypes related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.28 DNM1 DNM2 GDAP1 GJB1 LITAF MPZ

Drugs & Therapeutics for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Search Clinical Trials , NIH Clinical Center for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Genetic Tests for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Genetic tests related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:

# Genetic test Affiliating Genes
1 Charcot-Marie-Tooth Disease, Dominant Intermediate B 29 DNM2
2 Charcot-Marie-Tooth Disease, Type 2m 29

Anatomical Context for Charcot-Marie-Tooth Disease, Dominant Intermediate B

MalaCards organs/tissues related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:

40
Eye

Publications for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Articles related to Charcot-Marie-Tooth Disease, Dominant Intermediate B:

(show all 13)
# Title Authors PMID Year
1
Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. 56 6
19502294 2009
2
Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. 56 6
18560793 2008
3
Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. 56 6
17636067 2007
4
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. 56 6
15731758 2005
5
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review. 56
28364294 2017
6
DNM2-Related Intermediate Charcot-Marie-Tooth Neuropathy 6
20614582 2010
7
Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region. 56
12761657 2003
8
Reduction in the minimum candidate interval in the dominant-intermediate form of Charcot-Marie-Tooth neuropathy to D19S586 to D19S432. 56
12481986 2002
9
Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. 56
11533912 2001
10
Charcot-Marie-Tooth (CMT) Hereditary Neuropathy Overview 6
20301532 1998
11
The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. 56
752065 1978
12
Wide spectrum of motor conduction velocity in Charcot-Marie-Tooth disease. An anatomico-physiological interpretation. 56
4855423 1974
13
Zebrafish as a Model to Investigate Dynamin 2-Related Diseases. 61
26842864 2016

Variations for Charcot-Marie-Tooth Disease, Dominant Intermediate B

ClinVar genetic disease variations for Charcot-Marie-Tooth Disease, Dominant Intermediate B:

6 (show top 50) (show all 120) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 DNM2 DNM2, 9-BP DEL, NT1652deletion Pathogenic 7276
2 DNM2 NM_001005360.2(DNM2):c.1106G>A (p.Arg369Gln)SNV Pathogenic 7279 rs121909089 19:10904509-10904509 19:10793833-10793833
3 DNM2 NM_001005360.2(DNM2):c.1105C>T (p.Arg369Trp)SNV Pathogenic 7280 rs121909090 19:10904508-10904508 19:10793832-10793832
4 DNM2 NM_001005360.2(DNM2):c.1393C>T (p.Arg465Trp)SNV Pathogenic 7281 rs121909091 19:10909219-10909219 19:10798543-10798543
5 DNM2 NM_001005360.2(DNM2):c.1102G>A (p.Glu368Lys)SNV Pathogenic 7282 rs121909092 19:10904505-10904505 19:10793829-10793829
6 DNM2 NM_001005360.2(DNM2):c.1565G>A (p.Arg522His)SNV Pathogenic 158514 rs587783595 19:10922947-10922947 19:10812271-10812271
7 DNM2 NM_001005360.2(DNM2):c.1856C>T (p.Ser619Leu)SNV Pathogenic/Likely pathogenic 7285 rs121909095 19:10934538-10934538 19:10823862-10823862
8 DNM2 NM_001005360.2(DNM2):c.1072G>A (p.Gly358Arg)SNV Pathogenic/Likely pathogenic 7287 rs267606772 19:10904475-10904475 19:10793799-10793799
9 DNM2 NM_001005360.2(DNM2):c.1021G>A (p.Glu341Lys)SNV Likely pathogenic 218920 rs864309705 19:10904424-10904424 19:10793748-10793748
10 DNM2 NM_001005360.2(DNM2):c.1609G>A (p.Gly537Ser)SNV Likely pathogenic 246295 rs121909093 19:10922991-10922991 19:10812315-10812315
11 DNM2 NM_001005360.2(DNM2):c.1853C>A (p.Ala618Asp)SNV Likely pathogenic 465283 rs1555715869 19:10934535-10934535 19:10823859-10823859
12 DNM2 NM_001005360.2(DNM2):c.1463C>G (p.Thr488Arg)SNV Likely pathogenic 580216 rs746903992 19:10913004-10913004 19:10802328-10802328
13 DNM2 NM_001005360.2(DNM2):c.2179C>T (p.His727Tyr)SNV Conflicting interpretations of pathogenicity 327987 rs142963320 19:10939832-10939832 19:10829156-10829156
14 DNM2 NM_001005360.2(DNM2):c.1773G>A (p.Thr591=)SNV Conflicting interpretations of pathogenicity 327984 rs201604679 19:10930757-10930757 19:10820081-10820081
15 DNM2 NM_001005360.2(DNM2):c.1782-7C>ASNV Conflicting interpretations of pathogenicity 379457 rs200843089 19:10934457-10934457 19:10823781-10823781
16 DNM2 NM_001005360.2(DNM2):c.1384A>G (p.Thr462Ala)SNV Conflicting interpretations of pathogenicity 327980 rs201575500 19:10909210-10909210 19:10798534-10798534
17 DNM2 NM_001005360.2(DNM2):c.1609G>T (p.Gly537Cys)SNV Conflicting interpretations of pathogenicity 7283 rs121909093 19:10922991-10922991 19:10812315-10812315
18 DNM2 NM_001005360.2(DNM2):c.1709T>A (p.Leu570His)SNV Conflicting interpretations of pathogenicity 7284 rs121909094 19:10930693-10930693 19:10820017-10820017
19 DNM2 NM_001005360.2(DNM2):c.2231T>C (p.Val744Ala)SNV Conflicting interpretations of pathogenicity 465284 rs777609224 19:10939884-10939884 19:10829208-10829208
20 DNM2 NM_001005360.2(DNM2):c.958G>A (p.Asp320Asn)SNV Conflicting interpretations of pathogenicity 158529 rs150613209 19:10897348-10897348 19:10786672-10786672
21 DNM2 NM_001005360.2(DNM2):c.695T>A (p.Ile232Asn)SNV Uncertain significance 465292 rs749672066 19:10893642-10893642 19:10782966-10782966
22 DNM2 NM_001005360.2(DNM2):c.1304T>G (p.Leu435Arg)SNV Uncertain significance 533828 rs1555710681 19:10906844-10906844 19:10796168-10796168
23 DNM2 NM_001005360.2(DNM2):c.1552A>G (p.Ile518Val)SNV Uncertain significance 533834 rs753402698 19:10919251-10919251 19:10808575-10808575
24 DNM2 NM_001005360.2(DNM2):c.2023A>G (p.Met675Val)SNV Uncertain significance 533832 rs1555716140 19:10935862-10935862 19:10825186-10825186
25 DNM2 NM_001005360.2(DNM2):c.83A>T (p.His28Leu)SNV Uncertain significance 533830 rs774962668 19:10829001-10829001 19:10718325-10718325
26 DNM2 NM_001005360.2(DNM2):c.821C>T (p.Thr274Met)SNV Uncertain significance 533835 rs746387165 19:10893768-10893768 19:10783092-10783092
27 DNM2 NM_001005360.2(DNM2):c.177C>A (p.Arg59=)SNV Uncertain significance 533833 rs762795230 19:10870429-10870429 19:10759753-10759753
28 DNM2 NM_001005360.2(DNM2):c.1718G>A (p.Arg573His)SNV Uncertain significance 533831 rs1555715216 19:10930702-10930702 19:10820026-10820026
29 DNM2 NM_001005360.2(DNM2):c.2497T>C (p.Ser833Pro)SNV Uncertain significance 533829 rs1253864930 19:10941008-10941008 19:10830332-10830332
30 DNM2 NM_001005360.2(DNM2):c.161+3G>ASNV Uncertain significance 533826 rs1555696272 19:10829082-10829082 19:10718406-10718406
31 DNM2 NM_001005360.2(DNM2):c.889C>T (p.Arg297Cys)SNV Uncertain significance 533827 rs760254039 19:10897279-10897279 19:10786603-10786603
32 DNM2 NM_001005360.2(DNM2):c.197G>A (p.Arg66Gln)SNV Uncertain significance 562194 rs1568283807 19:10870449-10870449 19:10759773-10759773
33 DNM2 NM_001005360.2(DNM2):c.535A>G (p.Met179Val)SNV Uncertain significance 581147 rs748887276 19:10886528-10886528 19:10775852-10775852
34 DNM2 NM_001005360.2(DNM2):c.797G>A (p.Arg266Gln)SNV Uncertain significance 575548 rs754507545 19:10893744-10893744 19:10783068-10783068
35 DNM2 NM_001005360.2(DNM2):c.800A>G (p.His267Arg)SNV Uncertain significance 578383 rs1412618988 19:10893747-10893747 19:10783071-10783071
36 DNM2 NM_001005360.2(DNM2):c.819C>T (p.Gly273=)SNV Uncertain significance 572382 rs1464745378 19:10893766-10893766 19:10783090-10783090
37 DNM2 NM_001005360.2(DNM2):c.992+4T>CSNV Uncertain significance 571848 rs1225723240 19:10897386-10897386 19:10786710-10786710
38 DNM2 NM_001005360.2(DNM2):c.1731G>C (p.Lys577Asn)SNV Uncertain significance 571093 rs35365412 19:10930715-10930715 19:10820039-10820039
39 DNM2 NM_001005360.2(DNM2):c.2197C>T (p.Leu733Phe)SNV Uncertain significance 578871 rs1568324227 19:10939850-10939850 19:10829174-10829174
40 DNM2 NM_001005360.2(DNM2):c.2286C>A (p.Ser762Arg)SNV Uncertain significance 583006 rs1568324385 19:10939939-10939939 19:10829263-10829263
41 DNM2 NM_001005360.2(DNM2):c.868C>T (p.Arg290Trp)SNV Uncertain significance 133980 rs587778235 19:10897258-10897258 19:10786582-10786582
42 DNM2 NM_001005360.2(DNM2):c.1273C>A (p.Leu425Met)SNV Uncertain significance 245878 rs879253980 19:10906813-10906813 19:10796137-10796137
43 DNM2 NM_001005360.2(DNM2):c.1772C>T (p.Thr591Met)SNV Uncertain significance 327983 rs372876881 19:10930756-10930756 19:10820080-10820080
44 DNM2 NM_001005360.2(DNM2):c.1051G>A (p.Val351Met)SNV Uncertain significance 234708 rs876661176 19:10904454-10904454 19:10793778-10793778
45 DNM2 NM_001005360.2(DNM2):c.1969C>T (p.Arg657Cys)SNV Uncertain significance 246008 rs772920450 19:10935808-10935808 19:10825132-10825132
46 DNM2 NM_001005360.2(DNM2):c.2276G>A (p.Ser759Asn)SNV Uncertain significance 246533 rs879254300 19:10939929-10939929 19:10829253-10829253
47 DNM2 NM_001005360.2(DNM2):c.890G>A (p.Arg297His)SNV Uncertain significance 327977 rs763894364 19:10897280-10897280 19:10786604-10786604
48 DNM2 NM_001005360.2(DNM2):c.481C>A (p.Leu161Met)SNV Uncertain significance 411952 rs1060503547 19:10886474-10886474 19:10775798-10775798
49 DNM2 NM_001005360.2(DNM2):c.699C>T (p.Gly233=)SNV Uncertain significance 411951 rs751844947 19:10893646-10893646 19:10782970-10782970
50 DNM2 NM_001005360.2(DNM2):c.934G>A (p.Glu312Lys)SNV Uncertain significance 411953 rs370636702 19:10897324-10897324 19:10786648-10786648

UniProtKB/Swiss-Prot genetic disease variations for Charcot-Marie-Tooth Disease, Dominant Intermediate B:

73
# Symbol AA change Variation ID SNP ID
1 DNM2 p.Lys562Glu VAR_031967 rs121909088
2 DNM2 p.Gly537Cys VAR_062574 rs121909093
3 DNM2 p.Leu570His VAR_062575 rs121909094
4 DNM2 p.Gly358Arg VAR_068425 rs267606772

Expression for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Search GEO for disease gene expression data for Charcot-Marie-Tooth Disease, Dominant Intermediate B.

Pathways for Charcot-Marie-Tooth Disease, Dominant Intermediate B

GO Terms for Charcot-Marie-Tooth Disease, Dominant Intermediate B

Cellular components related to Charcot-Marie-Tooth Disease, Dominant Intermediate B according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 cytoplasm GO:0005737 9.97 YARS1 SBF2 RAB7A PLEK MTMR2 MTMR14
2 cytoplasmic vesicle GO:0031410 9.83 SH3TC2 RAB7B RAB7A DNM2 DNM1
3 axon GO:0030424 9.78 SBF2 MTMR2 DNM2 DNM1
4 lysosome GO:0005764 9.76 RAB7B RAB7A MPZ LITAF
5 dendritic spine GO:0043197 9.7 MTMR2 DNM2 DNM1
6 late endosome GO:0005770 9.67 RAB7B RAB7A MTM1
7 late endosome membrane GO:0031902 9.58 RAB7B RAB7A LITAF
8 endosome membrane GO:0010008 9.56 SBF2 RAB7A MTMR2 LITAF
9 vacuolar membrane GO:0005774 9.51 SBF2 MTMR2
10 phagocytic vesicle membrane GO:0030670 9.5 RAB7B RAB7A DNM2
11 dendritic spine head GO:0044327 9.37 DNM2 DNM1
12 endosome GO:0005768 9.17 SBF2 RAB7B RAB7A MTMR2 MTM1 LITAF
13 postsynaptic endocytic zone membrane GO:0098844 8.96 DNM2 DNM1

Biological processes related to Charcot-Marie-Tooth Disease, Dominant Intermediate B according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 dephosphorylation GO:0016311 9.69 MTMR2 MTMR14 MTM1
2 peptidyl-tyrosine dephosphorylation GO:0035335 9.61 MTMR2 MTMR14 MTM1
3 phosphatidylinositol biosynthetic process GO:0006661 9.5 MTMR2 MTMR14 MTM1
4 phosphatidylinositol metabolic process GO:0046488 9.49 PLEK MTMR2
5 phosphatidylinositol dephosphorylation GO:0046856 9.48 MTMR2 MTM1
6 G protein-coupled receptor internalization GO:0002031 9.46 DNM2 DNM1
7 regulation of synapse structure or activity GO:0050803 9.4 DNM2 DNM1
8 postsynaptic neurotransmitter receptor internalization GO:0098884 9.37 DNM2 DNM1
9 phagosome-lysosome fusion GO:0090385 9.26 RAB7B RAB7A
10 synaptic vesicle budding from presynaptic endocytic zone membrane GO:0016185 9.16 DNM2 DNM1
11 endosome to lysosome transport GO:0008333 9.13 RAB7B RAB7A MTM1
12 mitochondrial fission GO:0000266 8.8 GDAP1 DNM2 DNM1

Molecular functions related to Charcot-Marie-Tooth Disease, Dominant Intermediate B according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 GTP binding GO:0005525 9.71 RAB7B RAB7A DNM2 DNM1
2 GTPase activity GO:0003924 9.67 RAB7B RAB7A DNM2 DNM1
3 WW domain binding GO:0050699 9.43 LITAF DNM2
4 protein tyrosine phosphatase activity GO:0004725 9.43 MTMR2 MTMR14 MTM1
5 nitric-oxide synthase binding GO:0050998 9.32 DNM2 DNM1
6 phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity GO:0052629 9.16 MTMR2 MTM1
7 D2 dopamine receptor binding GO:0031749 8.96 DNM2 DNM1
8 phosphatidylinositol-3-phosphatase activity GO:0004438 8.8 MTMR2 MTMR14 MTM1

Sources for Charcot-Marie-Tooth Disease, Dominant Intermediate B

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....